Leucovorin
Showing 1 - 25 of 1,644
Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)
Not yet recruiting
- Metastatic Pancreatic Cancer
- nanoliposomal irinotecan
- spleen irradiation
- (no location specified)
May 8, 2022
Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)
Terminated
- Colorectal Cancer
- Regorafenib
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 10, 2022
Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemo Trial in Taiwan (leucovorin, oxaliplatin, docetaxel, S-1)
Recruiting
- Gastric Cancer
- +3 more
- leucovorin, oxaliplatin, docetaxel, S-1
-
Kaohsiung, Taiwan
- +3 more
May 24, 2022
Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Onvansertib
- +3 more
-
Phoenix, Arizona
- +5 more
Jun 16, 2022
Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,
Recruiting
- Colorectal Cancer
- +4 more
- Fosifloxuridine Nafalbenamide
- +4 more
-
Wichita, Kansas
- +5 more
Jan 9, 2023
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Not yet recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jun 9, 2022
Advanced Biliary Tract Cancer Trial in Washington, Indianapolis, Saint Louis (Nanoliposomal Irinotecan, Leucovorin,
Recruiting
- Advanced Biliary Tract Cancer
- Nanoliposomal Irinotecan
- +2 more
-
Washington, District of Columbia
- +2 more
Oct 29, 2021
Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma Trial in Chicago (Oxaliplatin, Docetaxel,
Recruiting
- Pancreatic Adenocarcinoma
- +2 more
- Oxaliplatin
- +4 more
-
Chicago, IllinoisThe University of Chicago
Jun 7, 2021
Autism Spectrum Disorder Trial in United States (Folinic Acid, Placebo)
Recruiting
- Autism Spectrum Disorder
- Folinic Acid
- Placebo
-
Phoenix, Arizona
- +3 more
Jan 13, 2022
Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,
Not yet recruiting
- Pancreatic Cancer
- +3 more
- mFOLFIRINOX
- +7 more
-
Boston, Massachusetts
- +1 more
Sep 16, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,
Completed
- Adult Anaplastic Astrocytoma
- +6 more
- E. coli CD-expressing genetically modified neural stem cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 28, 2021
Pneumonia, Pneumocystis Carinii, HIV Trial in United States (Trimetrexate glucuronate, Sulfamethoxazole-Trimethoprim, Leucovorin
Completed
- Pneumonia, Pneumocystis Carinii
- HIV Infections
- Trimetrexate glucuronate
- +2 more
-
San Francisco, California
- +5 more
Oct 28, 2021
Intrahepatic Cholangiocarcinoma Trial in Guangzhou (oxaliplatin , fluorouracil, and leucovorin, gemcitabine and cisplatin)
Recruiting
- Intrahepatic Cholangiocarcinoma
- oxaliplatin , fluorouracil, and leucovorin
- gemcitabine and cisplatin
-
Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
Jul 7, 2021
Bladder Cancer, Urethral Cancer, Urachal Cancer Trial in Houston (5-Fluorouracil (5-FU), Leucovorin, Cisplatin)
Active, not recruiting
- Bladder Cancer
- +2 more
- 5-Fluorouracil (5-FU)
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 18, 2021
Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI + Cadonilimab, mFOLFOX6)
Not yet recruiting
- Colorectal Cancer
- mFOLFOXIRI + Cadonilimab
- mFOLFOX6
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Oct 17, 2022
Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)
Recruiting
- Colorectal Cancer
- mFOLFOXIRI plus Bevacizumab
- mFOLFOX6 Plus Bevacizumab
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022
Gastric Cancer by AJCC V8 Stage, Resectable Carcinoma Trial in Caen (perioperative treatment)
Recruiting
- Gastric Cancer by AJCC V8 Stage
- Resectable Carcinoma
- perioperative treatment
-
Caen, FranceCentre François Baclesse
Jun 28, 2021
Solid Tumors Trial in Singapore (ASLAN001+ CAPOX (Oxaliplatin, capecitabine), ASLAN001 + mFolfox6 (5-FU, leucovorin))
Active, not recruiting
- Solid Tumors
- ASLAN001+ CAPOX (Oxaliplatin, capecitabine)
- ASLAN001 + mFolfox6 (5-FU, leucovorin)
-
Singapore, SingaporeNational Cancer Centre
Apr 27, 2021
Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)
Recruiting
- Autism Spectrum Disorder
- Language Disorders
- Levoleucovorin Calcium
- Placebo
-
Phoenix, Arizona
- +1 more
Mar 8, 2021
Pneumonia, Pneumocystis Carinii, HIV Trial in West Columbia (Trimetrexate glucuronate, Methylprednisolone, Pentamidine
Terminated
- Pneumonia, Pneumocystis Carinii
- HIV Infections
- Trimetrexate glucuronate
- +4 more
-
West Columbia, South CarolinaJulio Arroyo
Oct 27, 2021
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles
Not yet recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Biospecimen Collection
- +9 more
-
Los Angeles, CaliforniaYonemoto,Lisa
Jan 13, 2023
Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)
Active, not recruiting
- Gastric Cancer
- Docetaxel
- +4 more
-
Mykolaiv, UkraineUkrainian Society of Clinical Oncology
Apr 11, 2022